Darlene M. Deptula-Hicks
Director, ACCEL BRANDS, INC.
Companies
- Aldeyra Therapeutics, Inc.Board member Jun 11, 2026 to now1
- F-star Therapeutics, Inc.Officer Mar 9, 2023 to Mar 9, 20232
- F-star Therapeutics, Inc.Chief financial officer Nov 24, 2020 to Apr 4, 20223
- Xenetic Biosciences (United States)Board member Nov 15, 2016 to Aug 23, 20174
- T2 Biosystems, Inc.Chief financial officer May 2, 2017 to Jun 8, 20175
- PALVELLA THERAPEUTICS, INC.Chief financial officer Jun 29, 2015 to Jun 15, 20166
- ICAD INCChief financial officer Sep 13, 2006 to Mar 31, 20117
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- F-star Therapeutics, Inc.0 shares8Mar 8, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 8, 2023Returned to company 25,539 shares at $7.12 of F-star Therapeutics, Inc.8
- Mar 8, 2023U 30,898 shares at $7.12 of F-star Therapeutics, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARF-star Therapeutics, Inc., Officer
- 3
- 4
- 5
- 6
- 7SEC EDGARICAD INC, Chief financial officer
- 8